Alpsoy et al.’s paper on BRD9 in PCa suggests that BRD9 could play a role in CRPC with BRD9 knockdown, reducing the viability of AR-positive cell lines (including castration-resistant cell lines) [19]. The gene discussed is BRD9; the disease is posterior cortical atrophy.